Cedric Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 35 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.39 Cr
- Satisfied Charges ₹ 1.50 Cr
- Revenue Growth -6.97%
- Profit Growth -53.15%
- Ebitda -26.95%
- Net Worth 6.11%
- Total Assets 12.48%
About Cedric Pharmaceuticals
Cedric Pharmaceuticals Private Limited (CPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 June 1989 and has a history of 35 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹4.39 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Saransh Sood, Anita Sood, and Yogesh Sood serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1989PTC036516
- Company No.
036516
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cedric Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saransh Sood  | Director | 09-Oct-2010 | Current |
| Anita Sood | Director | 05-Jun-1989 | Current |
| Yogesh Sood | Director | 16-Dec-1993 | Current |
Financial Performance of Cedric Pharmaceuticals.
Cedric Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.97% decrease. The company also saw a substantial fall in profitability, with a 53.15% decrease in profit. The company's net worth moved up by a moderate rise of 6.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cedric Pharmaceuticals?
In 2023, Cedric Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹43.95 M
₹15.00 M
Charges Breakdown by Lending Institutions
- Others : 4.12 Cr
- Hdfc Bank Limited : 0.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Sep 2024 | Others | ₹1.20 M | Open |
| 08 May 2023 | Hdfc Bank Limited | ₹1.20 M | Open |
| 26 Apr 2022 | Hdfc Bank Limited | ₹1.55 M | Open |
| 02 Aug 2016 | Others | ₹4.00 Cr | Open |
| 11 Oct 2011 | State Bank Of India | ₹1.50 Cr | Satisfied |
How Many Employees Work at Cedric Pharmaceuticals?
Unlock and access historical data on people associated with Cedric Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cedric Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cedric Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.